Status:
COMPLETED
Methylene Blue vs Cyanokit for Intraoperative Vasoplegic Syndrome in Liver Transplant Patients
Lead Sponsor:
Mayo Clinic
Conditions:
Vasoplegic Syndrome
Liver Transplant; Complications
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study will evaluate if Hydroxocobalamin may be a new and possibly superior treatment for refractory vasoplegic syndrome during liver transplant surgery.
Eligibility Criteria
Inclusion
- Patients scheduled to undergo liver transplantation
- Patients able to read and understand consent document (if patient is unable to provide an informed consent, the Legally Authorized Representative will be ask to consent on behalf of the patient).
- SVR lower than 500 dynes-sec/cm-5 intraoperatively (this criterion must be met after consent intraoperatively)
Exclusion
Key Trial Info
Start Date :
November 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 27 2024
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT04054999
Start Date
November 30 2019
End Date
February 27 2024
Last Update
June 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224